Presentation and outcomes of patients with multiple myeloma harboring gain or amplification of 1q21 and receiving novel agent therapies: results from a single-center study

Gain or amplification 1q21 (1q21+) is one of the most common recurrent cytogenetic abnormalities in multiple myeloma (MM). Our aim was to explore the presentation and outcomes of patients with MM harboring 1q21 + . We retrospectively analyzed the clinical features and survival outcomes in 474 consec...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hematology (Luxembourg) 2023-12, Vol.28 (1), p.2177979-2177979
Hauptverfasser:	Chen, Haimin, Zhou, Nian, Shi, Haotian, Yu, Wenjun, Wu, Lixia, Zhou, Fan
Format:	Artikel
Sprache:	eng
Schlagworte:	Chromosome Aberrations del(13q) gain/amplification 1q21 Humans Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - genetics PFS Prognosis Proteasome Inhibitors Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!